InvestSMART

Chrysos Corporation Limited (ASX:C79)

ALERT: Price-sensitive ASX Announcement for C79
Current share price for C79 : $5.820 -1.88 (-24.42%)+
Release
18 Feb 2026 8:54AM
Price at Release
$7.700
Full Release
download
Summary
Chrysos Corporation Limited reported a strong financial performance in the first half of FY26, driven by the increasing adoption of its PhotonAssayTM technology. The company recorded a total revenue of $43.3 million, a 49% increase compared to the previous corresponding period, and an EBITDA of $14.3 million, representing a 152% increase. Key factors contributing to this growth include strong gold prices, increased mining activities, and successful sales and marketing initiatives that led to the signing of new lease agreements and deployments. Chrysos also strengthened its financial position by securing a $200 million debt facility to support further growth. The company continued to expand its global presence with significant unit deployments and partnerships with major global geochemistry laboratories.
Key Points
  • Total revenue of $43.3 million, up 49% from 1H FY25.
  • EBITDA of $14.3 million, a 152% increase from 1H FY25.
  • EBITDA margin increased to 33% from 20% in 1H FY25.
  • Eight new lease agreements signed, total contracted units at 72.
  • Record sample volumes driven by strong gold prices and increased mining activities.
  • Secured a $200 million debt facility, improving financial position.
  • Expansion of global presence with partnerships and unit deployments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.